Half-year report · Q2
190A.TEDINET S100VLRA
Period2024-09-01 → 2025-02-28
Filed2025-04-11
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 41
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Operating income | −¥996m | 2024-09-01 → 2025-02-28 | Standalone | Operating income |
| Operating income | −¥810m | 2023-09-01 → 2024-02-29 | Standalone | Operating income |
| Ordinary income | −¥975m | 2024-09-01 → 2025-02-28 | Standalone | Ordinary income |
| Ordinary income | −¥1.8bn | 2023-09-01 → 2024-08-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥801m | 2023-09-01 → 2024-02-29 | Standalone | Ordinary income |
| Profit before tax | −¥975m | 2024-09-01 → 2025-02-28 | Standalone | Income before income taxes |
| Profit before tax | −¥801m | 2023-09-01 → 2024-02-29 | Standalone | Income before income taxes |
| Net income | −¥976m | 2024-09-01 → 2025-02-28 | Standalone | Profit loss |
| Net income | −¥1.8bn | 2023-09-01 → 2024-08-31 | Standalone | Net income loss (5-year summary) |
| Net income | −¥803m | 2023-09-01 → 2024-02-29 | Standalone | Profit loss |
| Total assets | ¥3.5bn | at 2025-02-28 | Standalone | Assets |
| Total assets | ¥4.6bn | at 2024-08-31 | Standalone | Assets |
| Total assets | ¥3.9bn | at 2024-02-29 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥205m | at 2025-02-28 | Standalone | Liabilities |
| Total liabilities | ¥471m | at 2024-08-31 | Standalone | Liabilities |
| Net assets / equity | ¥3.2bn | at 2025-02-28 | Standalone | Net assets |
| Net assets / equity | ¥4.2bn | at 2024-08-31 | Standalone | Net assets |
| Net assets / equity | ¥3.7bn | at 2024-02-29 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥3.3bn | at 2025-02-28 | Standalone | Cash and deposits |
| Cash and deposits | ¥4.3bn | at 2024-08-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥3.3bn | at 2025-02-28 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.3bn | at 2024-08-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥3.7bn | at 2024-02-29 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.8bn | at 2023-08-31d | Standalone | Cash and cash equivalents |
| Operating cash flow | −¥1.1bn | 2024-09-01 → 2025-02-28 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.9bn | 2023-09-01 → 2024-08-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.1bn | 2023-09-01 → 2024-02-29 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | −¥667,000 | 2024-09-01 → 2025-02-28 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥11m | 2023-09-01 → 2024-08-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥178,000 | 2023-09-01 → 2024-02-29 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | ¥62m | 2024-09-01 → 2025-02-28 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.5bn | 2023-09-01 → 2024-08-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-14.31 | 2024-09-01 → 2025-02-28 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-31.11 | 2023-09-01 → 2024-08-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-14.22 | 2023-09-01 → 2024-02-29 | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 94.0% | at 2025-02-28 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.8% | at 2024-08-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 94.1% | at 2024-02-29 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 68,988,800 | at 2025-02-28 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 67,678,800 | at 2024-08-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 56,443,800 | at 2024-02-29 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 328
| Item | Context | Value | Unit |
|---|---|---|---|
| Whether consolidated financial statements are prepared | FilingDateInstant | false | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Current fiscal year start date | FilingDateInstant | 2024-09-01 | |
| Current period end date | FilingDateInstant | 2025-02-28 | |
| Type of current period | FilingDateInstant | Q2 | |
| Current fiscal year end date | FilingDateInstant | 2025-08-31 | |
| Previous fiscal year start date | FilingDateInstant | 2023-09-01 | |
| Comparative period end date | FilingDateInstant | 2024-02-29 | |
| Previous fiscal year end date | FilingDateInstant | 2024-08-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所グロース市場 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)完全議決権株式であり、権利内容に何ら限定のない当社における標準となる株式であり、単元株式数は100株であります。 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Name major shareholders | CurrentQuarterInstant_No1MajorShareholdersMember | Original text (Japanese)武田薬品工業株式会社 | |
| Address major shareholders | CurrentQuarterInstant_No1MajorShareholdersMember | Original text (Japanese)大阪府大阪市中央区道修町四丁目１番１号 | |
| Name major shareholders | CurrentQuarterInstant_No2MajorShareholdersMember | Original text (Japanese)New Life Science １号投資事業有限責任組合 | |
| Address major shareholders | CurrentQuarterInstant_No2MajorShareholdersMember | Original text (Japanese)東京都港区虎ノ門五丁目１３番１号 | |
| Name major shareholders | CurrentQuarterInstant_No3MajorShareholdersMember | Original text (Japanese)イノベーション京都２０１６投資事業有限責任組合 | |
| Address major shareholders | CurrentQuarterInstant_No3MajorShareholdersMember | Original text (Japanese)京都府京都市左京区吉田本町３６番地１ | |
| Name major shareholders | CurrentQuarterInstant_No4MajorShareholdersMember | Original text (Japanese)日本グロースキャピタル投資法人 | |
| Address major shareholders | CurrentQuarterInstant_No4MajorShareholdersMember | Original text (Japanese)東京都千代田区大手町二丁目２番２号 | |
| Name major shareholders | CurrentQuarterInstant_No5MajorShareholdersMember | Original text (Japanese)MEDIPAL Innovation 投資事業有限責任組合 | |
| Address major shareholders | CurrentQuarterInstant_No5MajorShareholdersMember | Original text (Japanese)東京都港区六本木一丁目６番１号 | |
| Name major shareholders | CurrentQuarterInstant_No6MajorShareholdersMember | Original text (Japanese)三菱UFJライフサイエンス１号投資事業有限責任組合 | |
| Address major shareholders | CurrentQuarterInstant_No6MajorShareholdersMember | Original text (Japanese)東京都中央区日本橋二丁目３番４号 | |
| Name major shareholders | CurrentQuarterInstant_No7MajorShareholdersMember | Original text (Japanese)京大ベンチャーNVCC２号投資事業有限責任組合 | |
| Address major shareholders | CurrentQuarterInstant_No7MajorShareholdersMember | Original text (Japanese)東京都千代田区丸の内二丁目４番１号 | |
| Name major shareholders | CurrentQuarterInstant_No8MajorShareholdersMember | Original text (Japanese)山田祥美 | |
| Address major shareholders | CurrentQuarterInstant_No8MajorShareholdersMember | Original text (Japanese)東京都中野区 | |
| Name major shareholders | CurrentQuarterInstant_No9MajorShareholdersMember | Original text (Japanese)楽天証券株式会社 | |
| Address major shareholders | CurrentQuarterInstant_No9MajorShareholdersMember | Original text (Japanese)東京都港区南青山二丁目６番２１号 | |
| Name major shareholders | CurrentQuarterInstant_No10MajorShareholdersMember | Original text (Japanese)株式会社メディパルホールディングス |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |